Memantina Flas Stada (Memantine)

Memantine acts as a non‑competitive antagonist at the NMDA receptor, reducing excessive calcium influx caused by overstimulation of glutamate. This modulation protects neurons from excitotoxic damage, helping to preserve synaptic function and mitigate the neurodegenerative processes seen in Alzheimer’s disease.

The specific dose of Memantina Flas Stada is determined by the prescribing physician based on the patient’s clinical condition, age, renal function, and response to therapy. Dosage adjustments are made individually and should follow the prescriber’s instructions.

Safety data for memantine in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Memantine belongs to the NMDA receptor antagonist class, differing from cholinesterase inhibitors such as donepezil. While cholinesterase inhibitors increase acetylcholine levels, memantine reduces glutamate‑mediated excitotoxicity. In practice, memantine may be used alone or in combination with a cholinesterase inhibitor for additive benefit.

Memantina Flas Stada should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

The medication is taken orally, usually with or without food, as directed by the prescriber. Tablets (or oral solution, if applicable) should be swallowed whole and not crushed or chewed unless specifically instructed by a healthcare professional.

Serious adverse events, though uncommon, include seizures, cardiac arrhythmias, severe skin reactions such as Stevens‑Johnson syndrome, hepatic dysfunction, and emergence of suicidal thoughts. Patients should be monitored closely for any of these signs and seek immediate medical attention if they occur.

Memantina Flas Stada is contraindicated in patients with known hypersensitivity to memantine or any of the product’s excipients. Caution is advised for individuals with severe renal impairment, uncontrolled hypertension, or a history of seizures, and it should be avoided in those where the risk outweighs potential benefit.